Literature DB >> 26221386

Association of CYP2J2 gene polymorphisms with ischemic stroke.

Qing Li1, Jian-Hua Zhao1, Peng-Ju Ma2, Lin-Lin Su1, Sheng-Bo Tao1, Si-Bei Ji1.   

Abstract

OBJECTIVE: The present study aims to investigate the relationship between CYP2J2 gene polymorphisms and ischemic stroke (IS) in a Chinese Han population.
METHODS: We performed a case-control study including 300 stroke patients and 300 healthy control subjects to compare the distribution of genetic polymorphism G-50T in CYP2J2 gene.
RESULTS: We found GT genotype of G-50T in CYP2J2 gene was associated with the risk for IS (13.7% vs. 7.7%, P = 0.037). After adjustment of confounders, the difference remains significant (OR = 1.890, 95% CI: 1.042-3.011).
CONCLUSION: CYP2J2 gene polymorphism might increase the risk of stroke in Chinese population.

Entities:  

Keywords:  CYP2J2 gene; Ischemic stroke; single nucleotide polymorphism

Year:  2015        PMID: 26221386      PMCID: PMC4509331     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  16 in total

1.  The -50G>T polymorphism in the promoter of the CYP2J2 gene in coronary heart disease: the Ludwigshafen Risk and Cardiovascular Health study.

Authors:  Michael M Hoffmann; Peter Bugert; Ursula Seelhorst; Britta Wellnitz; Bernhard R Winkelmann; Bernhard O Boehm; Winfried März
Journal:  Clin Chem       Date:  2007-03       Impact factor: 8.327

2.  Common variation in cytochrome P450 epoxygenase genes and the risk of incident nonfatal myocardial infarction and ischemic stroke.

Authors:  Kristin D Marciante; Rheem A Totah; Susan R Heckbert; Nicholas L Smith; Rozenn N Lemaitre; Thomas Lumley; Kenneth M Rice; Lucia A Hindorff; Joshua C Bis; Brittany Hartman; Bruce M Psaty
Journal:  Pharmacogenet Genomics       Date:  2008-06       Impact factor: 2.089

3.  Association between polymorphisms of CYP2J2 and EPHX2 genes and risk of coronary artery disease.

Authors:  Yujun Xu; Hu Ding; Jia Peng; Guanglin Cui; Lei Liu; Katherine Cianflone; Dao Wen Wang
Journal:  Pharmacogenet Genomics       Date:  2011-08       Impact factor: 2.089

4.  Genetic variation in the G-50T polymorphism of the cytochrome P450 epoxygenase CYP2J2 gene and the risk of younger onset type 2 diabetes among Chinese population: potential interaction with body mass index and family history.

Authors:  C-P Wang; W-C Hung; T-H Yu; C-A Chiu; L-F Lu; F-M Chung; C-H Hung; S-J Shin; H-J Chen; Y-J Lee
Journal:  Exp Clin Endocrinol Diabetes       Date:  2010-02-05       Impact factor: 2.949

5.  Interaction between ALOX5AP and CYP3A5 gene variants significantly increases the risk for cerebral infarctions in Chinese.

Authors:  Li-Fen Chi; Xing-Yang Yi; Min-Jie Shao; Jing Lin; Qiang Zhou
Journal:  Neuroreport       Date:  2014-05-07       Impact factor: 1.837

6.  Genetic variation in cytochrome P450 2J2 and soluble epoxide hydrolase and risk of ischemic stroke in a Chinese population.

Authors:  Laxi Zhang; Hu Ding; Jiangtao Yan; Rutai Hui; Wei Wang; Grace E Kissling; Darryl C Zeldin; Dao Wen Wang
Journal:  Pharmacogenet Genomics       Date:  2008-01       Impact factor: 2.089

Review 7.  Genetics of cerebral small vessel disease.

Authors:  Jay Chol Choi
Journal:  J Stroke       Date:  2015-01-30       Impact factor: 6.967

8.  Inducible CYP2J2 and its product 11,12-EET promotes bacterial phagocytosis: a role for CYP2J2 deficiency in the pathogenesis of Crohn's disease?

Authors:  Jonas Bystrom; Scott J Thomson; Jörgen Johansson; Matthew L Edin; Darryl C Zeldin; Derek W Gilroy; Andrew M Smith; David Bishop-Bailey
Journal:  PLoS One       Date:  2013-09-13       Impact factor: 3.240

9.  Relationship between interleukin-10 -1082A/G polymorphism and risk of ischemic stroke: a meta-analysis.

Authors:  Jun Jin; Wuying Li; Lingmei Peng; Jian Chen; Rong Li; Peihua Wu; Sheng Tan
Journal:  PLoS One       Date:  2014-04-14       Impact factor: 3.240

10.  The CYP2J2 G-50T polymorphism and myocardial infarction in patients with cardiovascular risk profile.

Authors:  Jan Börgel; Daniel Bulut; Christoph Hanefeld; Horst Neubauer; Andreas Mügge; Jörg T Epplen; Tim Holland-Letz; Martin Spiecker
Journal:  BMC Cardiovasc Disord       Date:  2008-12-23       Impact factor: 2.298

View more
  4 in total

1.  CYP2J2 participates in atherogenesis by mediating cell proliferation, migration and foam cell formation.

Authors:  Rui Li; Yuan Zhang; Huacheng Yan; Hua Xiao; Yunjun Ruan; Jian Qiu; Lei Shi
Journal:  Mol Med Rep       Date:  2016-12-14       Impact factor: 2.952

2.  Association of CYP2J2 gene polymorphisms with ischemic stroke and stroke subtypes in Chinese population.

Authors:  Si-Yang Wang; Peng-Fei Xing; Chun-Yang Zhang; Ben-Qiang Deng
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

Review 3.  Regulation of CYP2J2 and EET Levels in Cardiac Disease and Diabetes.

Authors:  Theresa Aliwarga; Eric A Evangelista; Nona Sotoodehnia; Rozenn N Lemaitre; Rheem A Totah
Journal:  Int J Mol Sci       Date:  2018-06-29       Impact factor: 5.923

4.  Genetic polymorphisms of the drug-metabolizing enzyme CYP2J2 in a Tibetan population.

Authors:  Peilong Cao; Qian Zhao; Yuan Shao; Hua Yang; Tianbo Jin; Baiya Li; Honghui Li
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.